95 related articles for article (PubMed ID: 19624510)
1. Rapid identification of fungal pathogens in positive blood cultures using oligonucleotide array hybridization.
Hsiue HC; Huang YT; Kuo YL; Liao CH; Chang TC; Hsueh PR
Clin Microbiol Infect; 2010 May; 16(5):493-500. PubMed ID: 19624510
[TBL] [Abstract][Full Text] [Related]
2. Rapid identification of fungal pathogens in BacT/ALERT, BACTEC, and BBL MGIT media using polymerase chain reaction and DNA sequencing of the internal transcribed spacer regions.
Pryce TM; Palladino S; Price DM; Gardam DJ; Campbell PB; Christiansen KJ; Murray RJ
Diagn Microbiol Infect Dis; 2006 Apr; 54(4):289-97. PubMed ID: 16466900
[TBL] [Abstract][Full Text] [Related]
3. CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Tan GL; Peterson EM
J Clin Microbiol; 2005 Apr; 43(4):1727-31. PubMed ID: 15814992
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of BACTEC MYCO/F Lytic medium for recovery of mycobacteria, fungi, and bacteria from blood.
Fuller DD; Davis TE; Denys GA; York MK
J Clin Microbiol; 2001 Aug; 39(8):2933-6. PubMed ID: 11474016
[TBL] [Abstract][Full Text] [Related]
5. [Etiologic agents of fungemia in hospitalized patients].
Swoboda-Kopeć E; Rokosz A; Sawicka-Grzelak A; Wróblewska M; Krawczyk E; Stelmach E; Łuczak M
Med Dosw Mikrobiol; 2001; 53(3):291-5. PubMed ID: 11785187
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the BACTEC MYCO/F Lytic bottle to the isolator tube, BACTEC Plus Aerobic F/bottle, and BACTEC Anaerobic Lytic/10 bottle and comparison of the BACTEC Plus Aerobic F/bottle to the Isolator tube for recovery of bacteria, mycobacteria, and fungi from blood.
Vetter E; Torgerson C; Feuker A; Hughes J; Harmsen S; Schleck C; Horstmeier C; Roberts G; Cockerill F
J Clin Microbiol; 2001 Dec; 39(12):4380-6. PubMed ID: 11724848
[TBL] [Abstract][Full Text] [Related]
7. [Yeast-like fungi as etiologic agents of blood infections in patients hospitalized in 1998-1999].
Swoboda-Kopeć E; Sawicka-Grzelak A; Rokosz A; Wróblewska M; Sulik-Tyszka B; Stelmach E; łuczak M
Med Dosw Mikrobiol; 2002; 54(2):167-71. PubMed ID: 12185698
[TBL] [Abstract][Full Text] [Related]
8. [Multicenter study of fungemia due to yeasts in Argentina].
Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
[TBL] [Abstract][Full Text] [Related]
9. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
10. Candidemia and the susceptibility pattern of Candida isolates in blood.
Osoba AO; Al-Mowallad AW; McAlear DE; Hussein BA
Saudi Med J; 2003 Oct; 24(10):1060-3. PubMed ID: 14578968
[TBL] [Abstract][Full Text] [Related]
11. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
Durán MT; Velasco D; Canle D; Moure R; Villanueva R
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Isolator 1.5 and BACTEC NR660 aerobic 6A blood culture systems for detection of fungemia in children.
Petti CA; Zaidi AK; Mirrett S; Reller LB
J Clin Microbiol; 1996 Aug; 34(8):1877-9. PubMed ID: 8818873
[TBL] [Abstract][Full Text] [Related]
13. DNA microarray-based detection and identification of fungal pathogens in clinical samples from neutropenic patients.
Spiess B; Seifarth W; Hummel M; Frank O; Fabarius A; Zheng C; Mörz H; Hehlmann R; Buchheidt D
J Clin Microbiol; 2007 Nov; 45(11):3743-53. PubMed ID: 17715373
[TBL] [Abstract][Full Text] [Related]
14. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Tumbarello M; Sanguinetti M; Trecarichi EM; La Sorda M; Rossi M; de Carolis E; de Gaetano Donati K; Fadda G; Cauda R; Posteraro B
J Antimicrob Chemother; 2008 Dec; 62(6):1379-85. PubMed ID: 18782778
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and antifungal susceptibilities of Candida spp. to six antifungal agents: results from a surveillance study on fungaemia in Germany from July 2004 to August 2005.
Borg-von Zepelin M; Kunz L; Rüchel R; Reichard U; Weig M; Gross U
J Antimicrob Chemother; 2007 Aug; 60(2):424-8. PubMed ID: 17562683
[TBL] [Abstract][Full Text] [Related]
16. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-year period.
Comert F; Kulah C; Aktas E; Eroglu O; Ozlu N
Mycoses; 2007 Jan; 50(1):52-7. PubMed ID: 17302749
[TBL] [Abstract][Full Text] [Related]
17. Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
Cheng MF; Yu KW; Tang RB; Fan YH; Yang YL; Hsieh KS; Ho M; Lo HJ
Diagn Microbiol Infect Dis; 2004 Jan; 48(1):33-7. PubMed ID: 14761719
[TBL] [Abstract][Full Text] [Related]
18. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of a rapid trehalase test for the identification of Candida glabrata].
Kirdar S; Gültekin B; Evcil G; Ozkütük A; Sener AG; Aydin N
Mikrobiyol Bul; 2009 Apr; 43(2):303-7. PubMed ID: 19621617
[TBL] [Abstract][Full Text] [Related]
20. High-throughput identification of clinical pathogenic fungi by hybridization to an oligonucleotide microarray.
Huang A; Li JW; Shen ZQ; Wang XW; Jin M
J Clin Microbiol; 2006 Sep; 44(9):3299-305. PubMed ID: 16954264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
